Is Your Cold Chain Keeping You Up At Night?
In the highly regulated and complex world of biopharmaceutical drug products, ensuring the integrity...
read Details
Understanding + Applying Annex 1: New EU GMP
Understanding + Applying Annex 1: New EU GMP
The global regulatory experts at Modality Solutions provide a detailed, tactical approach for meeting the new requirements for container closure integrity (CCI) of sterile pharmaceutical products detailed in the revised Annex 1 EU GMP.
Download the slide deck created by industry experts, Andrew Larrigan and Carson Dickey to understand how the changes to EU Annex 1 will impact your cold chain strategy for container closure integrity.
Receive this webinar to your email
You may also like
Reliable Partnerships and Regulatory Assurance: The Backbone of Biopharma Logistics
In the highly regulated and complex world of biopharmaceutical drug products, ensuring the integrity...
read Details
Empowering Functional VPs: Strategic Guidance for Sustainable Cold Chain Success
In the highly regulated and complex world of biopharmaceutical drug products, ensuring the integrity...
read Details